ArticleJournal for immunotherapy of cancer2016

Fusion of the dendritic cell-targeting chemokine MIP3α to melanoma antigen Gp100 in a therapeutic DNA vaccine significantly enhances immunogenicity and survival in a mouse melanoma model.

James T Gordy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.